Merck (MRK) Current Deferred Tax Assets (2009 - 2023)

Merck has disclosed Current Deferred Tax Assets across 15 years of filings, most recently posting $6.6 billion for Q2 2023.

• In Q2 2023, Current Deferred Tax Assets fell 2.51% year-over-year to $6.6 billion; the TTM figure through Jun 2023 stood at $6.6 billion (down 2.51% YoY), while the FY2022 annual figure was $7.2 billion, up 2.6% from the prior year.
• Current Deferred Tax Assets retreated to $6.6 billion in Q2 2023, from $6.7 billion in the prior quarter.
• Over the last five years, Current Deferred Tax Assets for MRK reached as high as $7.2 billion in Q3 2022 and fell as low as $3.2 billion in Q1 2019.
• The 5-year median for Current Deferred Tax Assets is $6.0 billion (2021), against an average of $5.6 billion.
• Annual changes were most pronounced in 2019 — Current Deferred Tax Assets slipped 21.38% — and 2021, when it soared 49.49%.
• A 5-year view of Current Deferred Tax Assets shows it stood at $4.3 billion in 2019, then advanced by 9.28% to $4.7 billion in 2020, then soared by 49.49% to $7.0 billion in 2021, then increased by 2.6% to $7.2 billion in 2022, then fell by 7.39% to $6.6 billion in 2023.
• According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $6.6 billion, $6.7 billion, and $7.2 billion for Q2 2023, Q1 2023, and Q4 2022 respectively.